SARS-CoV-2 seroprevalence and clinical features of COVID-19 in a German liver transplant recipient cohort: a prospective serosurvey study
In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 May 2021
|
| In: |
Transplantation proceedings
Year: 2021, Volume: 53, Issue: 4, Pages: 1112-1117 |
| ISSN: | 1873-2623 |
| DOI: | 10.1016/j.transproceed.2020.11.009 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.transproceed.2020.11.009 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0041134520329043 |
| Author Notes: | Conrad Rauber, Shilpa Tiwari-Heckler, Jan Pfeiffenberger, Arianeb Mehrabi, Frederike Lund, Philip Gath, Markus Mieth, Uta Merle, and Christian Rupp |
| Summary: | In liver transplant (LT) recipients with severe coronavirus disease 2019 (COVID-19), fatal outcome has been reported in a substantial subset of patients. Whether LT recipients are at increased risk for severe COVID-19 compared with the general population is controversial. Here we report the results of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in a large LT recipient cohort. |
|---|---|
| Item Description: | Available online 16 December 2020 Gesehen am 22.09.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1873-2623 |
| DOI: | 10.1016/j.transproceed.2020.11.009 |